Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign in or Register to read more
16983
Related Questions
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
How do you identify patients with false positive AcHR antibodies?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
How do you approach a patient who develops a rest tremor after chemotherapy?
Do you perform EMG and repetitive nerve stimulation in patients with ocular myasthenia gravis, particularly those who are AChR-positive, to assess for electrophysiological evidence of generalized disease?
When do you use rozanolixizumab for Musk MG?
How frequently do you re-evaluate AChR and MuSK antibodies in patients with clinical and electrodiagnostic evidence of seronegative myasthenia gravis?
How do you consider sending fungal studies in a patient with pneumonia?